Cargando…
GLI1 regulates a novel neuropilin-2/α6β1 integrin based autocrine pathway that contributes to breast cancer initiation
The characterization of cells with tumour initiating potential is significant for advancing our understanding of cancer and improving therapy. Aggressive, triple-negative breast cancers (TNBCs) are enriched for tumour-initiating cells (TICs). We investigated that hypothesis that VEGF receptors expre...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
WILEY-VCH Verlag
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3628099/ https://www.ncbi.nlm.nih.gov/pubmed/23436775 http://dx.doi.org/10.1002/emmm.201202078 |
_version_ | 1782266375505444864 |
---|---|
author | Goel, Hira Lal Pursell, Bryan Chang, Cheng Shaw, Leslie M Mao, Junhao Simin, Karl Kumar, Prashant Vander Kooi, Craig W Shultz, Leonard D Greiner, Dale L Norum, Jens Henrik Toftgard, Rune Kuperwasser, Charlotte Mercurio, Arthur M |
author_facet | Goel, Hira Lal Pursell, Bryan Chang, Cheng Shaw, Leslie M Mao, Junhao Simin, Karl Kumar, Prashant Vander Kooi, Craig W Shultz, Leonard D Greiner, Dale L Norum, Jens Henrik Toftgard, Rune Kuperwasser, Charlotte Mercurio, Arthur M |
author_sort | Goel, Hira Lal |
collection | PubMed |
description | The characterization of cells with tumour initiating potential is significant for advancing our understanding of cancer and improving therapy. Aggressive, triple-negative breast cancers (TNBCs) are enriched for tumour-initiating cells (TICs). We investigated that hypothesis that VEGF receptors expressed on TNBC cells mediate autocrine signalling that contributes to tumour initiation. We discovered the VEGF receptor neuropilin-2 (NRP2) is expressed preferentially on TICs, involved in the genesis of TNBCs and necessary for tumour initiation. The mechanism by which NRP2 signalling promotes tumour initiation involves stimulation of the α6β1 integrin, focal adhesion kinase-mediated activation of Ras/MEK signalling and consequent expression of the Hedgehog effector GLI1. GLI1 also induces BMI-1, a key stem cell factor, and it enhances NRP2 expression and the function of α6β1, establishing an autocrine loop. NRP2 can be targeted in vivo to retard tumour initiation. These findings reveal a novel autocrine pathway involving VEGF/NRP2, α6β1 and GLI1 that contributes to the initiation of TNBC. They also support the feasibility of NRP2-based therapy for the treatment of TNBC that targets and impedes the function of TICs. |
format | Online Article Text |
id | pubmed-3628099 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | WILEY-VCH Verlag |
record_format | MEDLINE/PubMed |
spelling | pubmed-36280992013-04-19 GLI1 regulates a novel neuropilin-2/α6β1 integrin based autocrine pathway that contributes to breast cancer initiation Goel, Hira Lal Pursell, Bryan Chang, Cheng Shaw, Leslie M Mao, Junhao Simin, Karl Kumar, Prashant Vander Kooi, Craig W Shultz, Leonard D Greiner, Dale L Norum, Jens Henrik Toftgard, Rune Kuperwasser, Charlotte Mercurio, Arthur M EMBO Mol Med Research Article The characterization of cells with tumour initiating potential is significant for advancing our understanding of cancer and improving therapy. Aggressive, triple-negative breast cancers (TNBCs) are enriched for tumour-initiating cells (TICs). We investigated that hypothesis that VEGF receptors expressed on TNBC cells mediate autocrine signalling that contributes to tumour initiation. We discovered the VEGF receptor neuropilin-2 (NRP2) is expressed preferentially on TICs, involved in the genesis of TNBCs and necessary for tumour initiation. The mechanism by which NRP2 signalling promotes tumour initiation involves stimulation of the α6β1 integrin, focal adhesion kinase-mediated activation of Ras/MEK signalling and consequent expression of the Hedgehog effector GLI1. GLI1 also induces BMI-1, a key stem cell factor, and it enhances NRP2 expression and the function of α6β1, establishing an autocrine loop. NRP2 can be targeted in vivo to retard tumour initiation. These findings reveal a novel autocrine pathway involving VEGF/NRP2, α6β1 and GLI1 that contributes to the initiation of TNBC. They also support the feasibility of NRP2-based therapy for the treatment of TNBC that targets and impedes the function of TICs. WILEY-VCH Verlag 2013-04 2013-02-21 /pmc/articles/PMC3628099/ /pubmed/23436775 http://dx.doi.org/10.1002/emmm.201202078 Text en Copyright © 2013 The Authors. Published by John Wiley and Sons, Ltd on behalf of EMBO http://creativecommons.org/licenses/by/2.5/ This is an open access article under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Goel, Hira Lal Pursell, Bryan Chang, Cheng Shaw, Leslie M Mao, Junhao Simin, Karl Kumar, Prashant Vander Kooi, Craig W Shultz, Leonard D Greiner, Dale L Norum, Jens Henrik Toftgard, Rune Kuperwasser, Charlotte Mercurio, Arthur M GLI1 regulates a novel neuropilin-2/α6β1 integrin based autocrine pathway that contributes to breast cancer initiation |
title | GLI1 regulates a novel neuropilin-2/α6β1 integrin based autocrine pathway that contributes to breast cancer initiation |
title_full | GLI1 regulates a novel neuropilin-2/α6β1 integrin based autocrine pathway that contributes to breast cancer initiation |
title_fullStr | GLI1 regulates a novel neuropilin-2/α6β1 integrin based autocrine pathway that contributes to breast cancer initiation |
title_full_unstemmed | GLI1 regulates a novel neuropilin-2/α6β1 integrin based autocrine pathway that contributes to breast cancer initiation |
title_short | GLI1 regulates a novel neuropilin-2/α6β1 integrin based autocrine pathway that contributes to breast cancer initiation |
title_sort | gli1 regulates a novel neuropilin-2/α6β1 integrin based autocrine pathway that contributes to breast cancer initiation |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3628099/ https://www.ncbi.nlm.nih.gov/pubmed/23436775 http://dx.doi.org/10.1002/emmm.201202078 |
work_keys_str_mv | AT goelhiralal gli1regulatesanovelneuropilin2a6b1integrinbasedautocrinepathwaythatcontributestobreastcancerinitiation AT pursellbryan gli1regulatesanovelneuropilin2a6b1integrinbasedautocrinepathwaythatcontributestobreastcancerinitiation AT changcheng gli1regulatesanovelneuropilin2a6b1integrinbasedautocrinepathwaythatcontributestobreastcancerinitiation AT shawlesliem gli1regulatesanovelneuropilin2a6b1integrinbasedautocrinepathwaythatcontributestobreastcancerinitiation AT maojunhao gli1regulatesanovelneuropilin2a6b1integrinbasedautocrinepathwaythatcontributestobreastcancerinitiation AT siminkarl gli1regulatesanovelneuropilin2a6b1integrinbasedautocrinepathwaythatcontributestobreastcancerinitiation AT kumarprashant gli1regulatesanovelneuropilin2a6b1integrinbasedautocrinepathwaythatcontributestobreastcancerinitiation AT vanderkooicraigw gli1regulatesanovelneuropilin2a6b1integrinbasedautocrinepathwaythatcontributestobreastcancerinitiation AT shultzleonardd gli1regulatesanovelneuropilin2a6b1integrinbasedautocrinepathwaythatcontributestobreastcancerinitiation AT greinerdalel gli1regulatesanovelneuropilin2a6b1integrinbasedautocrinepathwaythatcontributestobreastcancerinitiation AT norumjenshenrik gli1regulatesanovelneuropilin2a6b1integrinbasedautocrinepathwaythatcontributestobreastcancerinitiation AT toftgardrune gli1regulatesanovelneuropilin2a6b1integrinbasedautocrinepathwaythatcontributestobreastcancerinitiation AT kuperwassercharlotte gli1regulatesanovelneuropilin2a6b1integrinbasedautocrinepathwaythatcontributestobreastcancerinitiation AT mercurioarthurm gli1regulatesanovelneuropilin2a6b1integrinbasedautocrinepathwaythatcontributestobreastcancerinitiation |